1	Nuclear	nuclear	_	_	_	_	_	_	_
2	NF-ATp	NF-ATp	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	hallmark	hallmark	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	unstimulated	unstimulated	_	_	_	_	_	_	_
8	B	b	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	B-CLL	B-CLL	_	_	_	_	_	_	_
12	patients	patient	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	B	B	_	_	_	_	_	_	_
2	lymphocytes	lymphocyte	_	_	_	_	_	_	_
3	from	from	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	peripheral	peripheral	_	_	_	_	_	_	_
6	blood	blood	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	patients	patient	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	chronic	chronic	_	_	_	_	_	_	_
11	lymphocytic	lymphocytic	_	_	_	_	_	_	_
12	leukaemia	leukaemia	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	CLL	CLL	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	were	be	_	_	_	_	_	_	_
17	analysed	analyse	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	nuclear	nuclear	_	_	_	_	_	_	_
21	presence	presence	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	DNA	dna	_	_	_	_	_	_	_
24	binding	binding	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	a	a	_	_	_	_	_	_	_
27	panel	panel	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	transcription	transcription	_	_	_	_	_	_	_
30	factors	factor	_	_	_	_	_	_	_
31	which	which	_	_	_	_	_	_	_
32	are	be	_	_	_	_	_	_	_
33	involved	involve	_	_	_	_	_	_	_
34	in	in	_	_	_	_	_	_	_
35	the	the	_	_	_	_	_	_	_
36	gene	gene	_	_	_	_	_	_	_
37	control	control	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	lymphoid	lymphoid	_	_	_	_	_	_	_
40	cells	cell	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	following	follow	_	_	_	_	_	_	_
3	transcription	transcription	_	_	_	_	_	_	_
4	factors	factor	_	_	_	_	_	_	_
5	were	be	_	_	_	_	_	_	_
6	studied	study	_	_	_	_	_	_	_
7	:	:	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	Octamer	Octamer	_	_	_	_	_	_	_
10	factors	factor	_	_	_	_	_	_	_
11	Oct-1	oct-1	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	Oct-2	oct-2	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	members	member	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	AP-1	ap-1	_	_	_	_	_	_	_
19	factor	factor	_	_	_	_	_	_	_
20	family	family	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	NF-AT	NF-AT	_	_	_	_	_	_	_
23	factors	factor	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	particular	particular	_	_	_	_	_	_	_
27	NF-ATp	nf-atp	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	members	member	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	Rel/NF-kB	Rel/NF-kB	_	_	_	_	_	_	_
34	family	family	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	show	show	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	constitutive	constitutive	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	translocation	translocation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	NF-ATp	NF-ATp	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	member	member	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	growing	grow	_	_	_	_	_	_	_
16	family	family	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	NF-AT	NF-AT	_	_	_	_	_	_	_
19	factors	factor	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	is	be	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	hallmark	hallmark	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	nonstimulated	nonstimulated	_	_	_	_	_	_	_
26	B	b	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	from	from	_	_	_	_	_	_	_
29	CLL	CLL	_	_	_	_	_	_	_
30	patients	patient	_	_	_	_	_	_	_
31	that	that	_	_	_	_	_	_	_
32	distinguishes	distinguish	_	_	_	_	_	_	_
33	B-CLL	B-CLL	_	_	_	_	_	_	_
34	cells	cell	_	_	_	_	_	_	_
35	from	from	_	_	_	_	_	_	_
36	‘	`	_	_	_	_	_	_	_
37	normal	normal	_	_	_	_	_	_	_
38	’	'	_	_	_	_	_	_	_
39	B	b	_	_	_	_	_	_	_
40	lymphocytes	lymphocyte	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	Constitutive	constitutive	_	_	_	_	_	_	_
2	nuclear	nuclear	_	_	_	_	_	_	_
3	appearance	appearance	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	also	also	_	_	_	_	_	_	_
6	observed	observe	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	NF-kB2/p52	nf-kb2/p52	_	_	_	_	_	_	_
9	.	.	_	_	_	_	_	_	_

1	Constitutive	constitutive	_	_	_	_	_	_	_
2	binding	binding	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	further	further	_	_	_	_	_	_	_
5	factor	factor	_	_	_	_	_	_	_
6	proteins	protein	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	DNA	DNA	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	such	such	_	_	_	_	_	_	_
11	as	as	_	_	_	_	_	_	_
12	JunD	JunD	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	c-Fos	c-fos	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	FosB	FosB	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	was	be	_	_	_	_	_	_	_
19	detected	detect	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	several	several	_	_	_	_	_	_	_
22	patients	patient	_	_	_	_	_	_	_
23	whereas	whereas	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	localisation	localisation	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	DNA	dna	_	_	_	_	_	_	_
28	binding	binding	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	other	other	_	_	_	_	_	_	_
31	factors	factor	_	_	_	_	_	_	_
32	such	such	_	_	_	_	_	_	_
33	as	as	_	_	_	_	_	_	_
34	c-Jun	c-jun	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	RelA/p65	rela/p65	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	c-Rel	c-rel	_	_	_	_	_	_	_
39	was	be	_	_	_	_	_	_	_
40	unaltered	unaltered	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	remarkable	remarkable	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	B-CLL	B-CLL	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	nuclear	nuclear	_	_	_	_	_	_	_
10	appearance	appearance	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	DNA	dna	_	_	_	_	_	_	_
13	binding	binding	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	specific	specific	_	_	_	_	_	_	_
16	transcription	transcription	_	_	_	_	_	_	_
17	factors	factor	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	dramatically	dramatically	_	_	_	_	_	_	_
20	affected	affect	_	_	_	_	_	_	_
21	whereas	whereas	_	_	_	_	_	_	_
22	other	other	_	_	_	_	_	_	_
23	members	member	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	same	same	_	_	_	_	_	_	_
27	factor	factor	_	_	_	_	_	_	_
28	family	family	_	_	_	_	_	_	_
29	remained	remain	_	_	_	_	_	_	_
30	unaltered	unaltered	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	these	these	_	_	_	_	_	_	_
33	leukemic	leukemic	_	_	_	_	_	_	_
34	cells	cell	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	remains	remain	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	be	be	_	_	_	_	_	_	_
5	shown	show	_	_	_	_	_	_	_
6	which	which	_	_	_	_	_	_	_
7	molecular	molecular	_	_	_	_	_	_	_
8	events	event	_	_	_	_	_	_	_
9	lead	lead	_	_	_	_	_	_	_
10	to	to	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	specific	specific	_	_	_	_	_	_	_
13	‘	`	_	_	_	_	_	_	_
14	pre-activation	pre-activation	_	_	_	_	_	_	_
15	’	'	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	i.e.	i.e.	_	_	_	_	_	_	_
18	constitutive	constitutive	_	_	_	_	_	_	_
19	nuclear	nuclear	_	_	_	_	_	_	_
20	translocation	translocation	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	DNA	dna	_	_	_	_	_	_	_
23	binding	binding	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	these	these	_	_	_	_	_	_	_
27	members	member	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	NF-AT	NF-AT	_	_	_	_	_	_	_
30	,	,	_	_	_	_	_	_	_
31	NF-kB	NF-kB	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	AP-1	ap-1	_	_	_	_	_	_	_
34	factor	factor	_	_	_	_	_	_	_
35	families	family	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

